NPI: 1336117670 · PENSACOLA, FL 32514 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,527 | $5.90M |
| 2019 | 20,540 | $1.32M |
| 2020 | 22,917 | $2.45M |
| 2021 | 19,584 | $645K |
| 2022 | 14,748 | $672K |
| 2023 | 4,177 | $139K |
| 2024 | 412 | $22K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 2,897 | 1,178 | $5.41M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,877 | 1,446 | $2.15M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,047 | 1,073 | $1.78M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,931 | 796 | $719K |
| J1756 | Injection, iron sucrose, 1 mg | 6,439 | 964 | $325K |
| 85048 | 1,578 | 820 | $100K | |
| 85041 | 1,578 | 823 | $99K | |
| 82728 | 1,437 | 746 | $91K | |
| 85045 | 1,435 | 754 | $90K | |
| 83540 | 1,426 | 742 | $89K | |
| 83550 | 1,429 | 742 | $89K | |
| 83970 | 1,191 | 603 | $83K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,085 | 581 | $78K |
| 82108 | 337 | 199 | $27K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 198 | 81 | $12K |
| G0008 | Administration of influenza virus vaccine | 20 | 12 | $2K |